Nasdaq
AIDX
20/20 Biolabs, Inc.
- Health Care
- 1 day
- +2.4%
- 1 month
- −22.8%
- 1 year
- —
$0.4519 · Mkt cap $5.54M
At the 6 Aug 2026 close
Nasdaq
20/20 Biolabs, Inc.
$0.4519 · Mkt cap $5.54M
At the 6 Aug 2026 close
20/20 Biolabs, Inc. trades under the ticker AIDX on Nasdaq, in the Health Care sector (Precision Instruments). Its market capitalisation is $5.54M. The last closing price was $0.4519, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because AIDX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.